Results 141 to 150 of about 1,816 (199)

Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report. [PDF]

Ophthalmol Ther, 2019
Meira J, Madeira C, Falcão-Reis F, Figueira L.   +3 more
europepmc   +1 more source

Real-world safety and efficacy of 0.19 mg fluocinolone acetonide intravitreal implant in the management of recurrent non-infectious uveitis [PDF]

, 2022
Christensen, Louise Fischer, Vorum, Henrik   +1 more
core   +3 more sources

Real-world experience with 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN) in the United Kingdom. [PDF]

Eye (Lond), 2017
Bailey C, Chakravarthy U, Lotery A, Menon G, Talks J, Medisoft Audit Group.   +5 more
europepmc   +1 more source

Acute postoperative complications after scleral fixation of Akreos AO60 intraocular lens. [PDF]

J Surg Case Rep
Grassi P, Tsoutsanis P, Henderson R.
europepmc   +1 more source

Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years. [PDF]

BMC Ophthalmol, 2018
Fusi-Rubiano W, Mukherjee C, Lane M, Tsaloumas MD, Glover N, Kidess A, Denniston AK, Palmer HE, Manna A, Morjaria R.   +9 more
europepmc   +1 more source

Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema. [PDF]

J Vitreoretin Dis
Godel S, Oncel D, Donkor R, Coney JM.
europepmc   +1 more source

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review. [PDF]

Ophthalmol Ther
Sacconi R, Scarinci F, Grassi MO, Covello G, Lo Giudice G, De Siena E, Cacace V, Gallinaro V, Dell'Omo R.   +8 more
europepmc   +1 more source

Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]

Drug Des Devel Ther
Tao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc   +1 more source

Comment on the Review: Clarifying Steroid-Associated Glaucoma-From Association to an Actionable Closed-Loop [Letter]. [PDF]

J Inflamm Res
Xu L, Chen X, Liu G.
europepmc   +1 more source